Tag: Pharmaceuticals
US: Fed lawsuit accuses 3 insulin manufacturers of conspiring to raise...
A federal lawsuit is accusing three of the biggest drug manufacturers of insulin of conspiring together to raise their prices, but the pharmaceutical companies...
An Examination of the Proposed Teva-Allergan Merger
By William S. Comanor & Diana L. Moss -
The proposed Teva-Allergan merger joins the largest generic pharmaceutical company in the world, Teva Pharmaceuticals, with an...
Feb-09(2)
In this issue:
The EC Pharmaceutical Sector Inquiry
Kent Bernard, Feb 23, 2009
Solving the Wrong Problem The Preliminary Report on the EC Pharmaceutical Sector Inquiry: What...
JUL-12(2)
The final issue in our health series brings in a global perspective. Four of our authors take a look at the EU approach to...
JUN-12(2)
With the Supreme Court ruling on Obama Care, much of the business world is focused on healthcare. In honor of that attention, we decided...
Nov-08(1)
The EC Pharmaceutical Report
Kent Bernard, Nov 12, 2008
The 2008 EC Sector Inquiry Regarding Pharmaceuticals: What Does It Mean from a Research-Based Company Perspective?
A sector...
Feb-08(1) & (2)
In this issue:
The European Commission's Sector Inquiry of Pharmaceuticals
Kent Bernard, Feb 06, 2008
The EC Sector Inquiry Regarding Pharmaceuticals: Some Thoughts from a...
Supreme Court Rules in Reverse Payment Case
Kevin Noonan, Sep 30, 2013
In June, the Supreme Court ruled 5-3 in favor of the Federal Trade Commission in FTC v. Actavis, Inc. Writing...
Reverse Payments After Actavis
John Bigelow, Sep 30, 2013
Thirteen years ago-in 2000-the Federal Trade Commission ("FTC") and private plaintiffs began fighting certain kinds of settlements that sometimes arise...
Canada’s Updated Draft Intellectual Property Enforcement Guidelines and the Pharmaceutical Industry
This article is part of a Chronicle. See more from this Chronicle
Anita Banicevic, Mark Katz, Oct 14, 2015
In June 2015, Canada’s Competition Bureau released...
